Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
33.43
-0.42 (-1.24%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Veracyte Employees
Veracyte had 755 employees as of December 31, 2025. The number of employees decreased by 69 or -8.37% compared to the previous year.
Employees
755
Change (1Y)
-69
Growth (1Y)
-8.37%
Revenue / Employee
$684,960
Profits / Employee
$87,885
Market Cap
2.67B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ICON Public Limited Company | 41,900 |
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
VCYT News
- 19 hours ago - Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers - Business Wire
- 14 days ago - Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026 - Business Wire
- 6 weeks ago - Veracyte Names Kevin Haas as Chief Development and Technology Officer - Business Wire
- 7 weeks ago - Veracyte Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Veracyte Transcript: 47th Annual Raymond James Institutional Investor Conference - Transcripts
- 2 months ago - Veracyte Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 2 months ago - Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium - Business Wire